Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients.

Journal article

Peer reviewed

RJ Manders, SF Praet, RC Meex, R Koopman, AL de Roos, AJ Wagenmakers, WH Saris and LJ van Loon

Diabetes Care, Vol.29(12), pp.2721-2722

12/2006

Abstract

Administration

Oral

Adult

Blood Glucose

Circadian Rhythm

Diabetes Mellitus

Type 2

Humans

Hyperglycemia

Leucine

Prevalence

Protein Hydrolysates

Reference Values

url

http://www.ncbi.nlm.nih.gov/pubmed/17130211View

Author

39 Record Views

Title: Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients.
Creators: RJ Manders
SF Praet
RC Meex
R Koopman
AL de Roos
AJ Wagenmakers
WH Saris
LJ van Loon
Publication Details: Diabetes Care, Vol.29(12), pp.2721-2722
Date published: 12/2006
Date submitted: 17/05/2017
Identifiers: 99516700302346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article